Väljaminev kiriAvalik
Farmakopöa töökava asjus
Ravimiamet · 4. november 2024
- Viit
- REP-1/4002-2
- Registreeritud
- 4. november 2024
- Dokumendi liik
- Väljaminev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2024
- Vastutaja
- Signe Leito (RA, Labor)
Sisu (failidest)
Deletion of the revision of Methylprednisolone hydrogen succinate (1131)
from the work programme (Group10B).
page 1 / 3
Q1-4 (3668)
NPA: (47938)
Type: (!/list-dropdown)
A10 - Estonia (EE)
Do you agree with the deletion of Methylprednisolone hydrogen succinate (1131) from the
work programme? (47939)
Type: (L/list-radio)
Yes
A1
If no, please provide further information. (47940)
Type: (T/text-long)
-
page 2 / 3
Remarks: (47941)
Type: (T/text-long)
-
page 3 / 3